These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 29153456

  • 1. Association of Mortality with Ocular Diseases and Visual Impairment in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 13.
    Age-Related Eye Disease Study 2 Research Group, Papudesu C, Clemons TE, Agrón E, Chew EY.
    Ophthalmology; 2018 Apr; 125(4):512-521. PubMed ID: 29153456
    [Abstract] [Full Text] [Related]

  • 2. No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18.
    van Asten F, Chiu CY, Agrón E, Clemons TE, Ratnapriya R, Swaroop A, Klein ML, Fan R, Chew EY, Age-Related Eye Disease Study 2 Research Group.
    Ophthalmology; 2019 Nov; 126(11):1541-1548. PubMed ID: 31358387
    [Abstract] [Full Text] [Related]

  • 3. Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28.
    Chew EY, Clemons TE, Agrón E, Domalpally A, Keenan TDL, Vitale S, Weber C, Smith DC, Christen W, AREDS2 Research Group.
    JAMA Ophthalmol; 2022 Jul 01; 140(7):692-698. PubMed ID: 35653117
    [Abstract] [Full Text] [Related]

  • 4. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.
    Age-Related Eye Disease Study 2 (AREDS2) Research Group, Chew EY, Clemons TE, Sangiovanni JP, Danis RP, Ferris FL, Elman MJ, Antoszyk AN, Ruby AJ, Orth D, Bressler SB, Fish GE, Hubbard GB, Klein ML, Chandra SR, Blodi BA, Domalpally A, Friberg T, Wong WT, Rosenfeld PJ, Agrón E, Toth CA, Bernstein PS, Sperduto RD.
    JAMA Ophthalmol; 2014 Feb 01; 132(2):142-9. PubMed ID: 24310343
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
    Age-Related Eye Disease Study 2 Research Group.
    JAMA; 2013 May 15; 309(19):2005-15. PubMed ID: 23644932
    [Abstract] [Full Text] [Related]

  • 7. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).
    AREDS2 Research GroupDivision of Epidemiology and Clinical Applications, National Eye Institute/National Institutes of Health, Bethesda, Maryland, USA. echew@nei.nih.gov, Chew EY, Clemons T, SanGiovanni JP, Danis R, Domalpally A, McBee W, Sperduto R, Ferris FL.
    Ophthalmology; 2012 Nov 15; 119(11):2282-9. PubMed ID: 22840421
    [Abstract] [Full Text] [Related]

  • 8. Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4.
    Age-Related Eye Disease Study 2 (AREDS2) Research GroupNational Eye Institute/National Institutes of Health, Bethesda, MD 20892, USA., Chew EY, SanGiovanni JP, Ferris FL, Wong WT, Agron E, Clemons TE, Sperduto R, Danis R, Chandra SR, Blodi BA, Domalpally A, Elman MJ, Antoszyk AN, Ruby AJ, Orth D, Bressler SB, Fish GE, Hubbard GB, Klein ML, Friberg TR, Rosenfeld PJ, Toth CA, Bernstein P.
    JAMA Ophthalmol; 2013 Jul 15; 131(7):843-50. PubMed ID: 23645227
    [Abstract] [Full Text] [Related]

  • 9. Visual acuity after cataract surgery in patients with age-related macular degeneration: age-related eye disease study 2 report number 5.
    Age-Related Eye Disease Study 2 Research Group, Huynh N, Nicholson BP, Agrón E, Clemons TE, Bressler SB, Rosenfeld PJ, Chew EY.
    Ophthalmology; 2014 Jun 15; 121(6):1229-36. PubMed ID: 24613825
    [Abstract] [Full Text] [Related]

  • 10. The Association of Statin Use with Age-Related Macular Degeneration Progression: The Age-Related Eye Disease Study 2 Report Number 9.
    Al-Holou SN, Tucker WR, Agrón E, Clemons TE, Cukras C, Ferris FL, Chew EY, Age-Related Eye Disease Study 2 Research Group.
    Ophthalmology; 2015 Dec 15; 122(12):2490-6. PubMed ID: 26435335
    [Abstract] [Full Text] [Related]

  • 11. A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14.
    van Asten F, Simmons M, Singhal A, Keenan TD, Ratnapriya R, Agrón E, Clemons TE, Swaroop A, Lu Z, Chew EY, Age-Related Eye Disease Study 2 Research Group.
    Ophthalmology; 2018 Apr 15; 125(4):559-568. PubMed ID: 29096998
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial.
    Chew EY, Clemons TE, Agrón E, Launer LJ, Grodstein F, Bernstein PS, Age-Related Eye Disease Study 2 (AREDS2) Research Group.
    JAMA; 2015 Aug 25; 314(8):791-801. PubMed ID: 26305649
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.